Cargando…

Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

INTRODUCTION: Systematic documentation of chemotoxicities in outpatient clinics is challenging. Incorporating patient-reported outcome (PRO) measures in clinical workflows can be an efficient strategy to strengthen the assessment of symptomatic treatment toxicities in oncology clinical practice. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tian Qi, Samuel, Joseph N., Brown, M. Catherine, Vennettilli, Ashlee, Solomon, Hannah, Eng, Lawson, Liang, Mindy, Gill, Gursharan, Merali, Zahra, Tian, Chenchen, Cheng, Nicholas Y. H., Campbell, Matthew, Patel, Devalben, Liu, Ai Xin, Liu, Geoffrey, Howell, Doris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360011/
https://www.ncbi.nlm.nih.gov/pubmed/32700029
http://dx.doi.org/10.1007/s40487-018-0065-7
_version_ 1783559152791977984
author Wang, Tian Qi
Samuel, Joseph N.
Brown, M. Catherine
Vennettilli, Ashlee
Solomon, Hannah
Eng, Lawson
Liang, Mindy
Gill, Gursharan
Merali, Zahra
Tian, Chenchen
Cheng, Nicholas Y. H.
Campbell, Matthew
Patel, Devalben
Liu, Ai Xin
Liu, Geoffrey
Howell, Doris
author_facet Wang, Tian Qi
Samuel, Joseph N.
Brown, M. Catherine
Vennettilli, Ashlee
Solomon, Hannah
Eng, Lawson
Liang, Mindy
Gill, Gursharan
Merali, Zahra
Tian, Chenchen
Cheng, Nicholas Y. H.
Campbell, Matthew
Patel, Devalben
Liu, Ai Xin
Liu, Geoffrey
Howell, Doris
author_sort Wang, Tian Qi
collection PubMed
description INTRODUCTION: Systematic documentation of chemotoxicities in outpatient clinics is challenging. Incorporating patient-reported outcome (PRO) measures in clinical workflows can be an efficient strategy to strengthen the assessment of symptomatic treatment toxicities in oncology clinical practice. We compared the adequateness, feasibility, and acceptability of toxicity documentation using systematic, prospective, application of the PRO Common Toxicity Criteria for Adverse Events (PRO-CTCAE) tool. METHODS: At a comprehensive cancer center, data abstraction of electronic health record reviews elucidated current methods and degree of chemotoxicity documentation. Web-based 32-item PRO-CTCAE questionnaires, administered in ambulatory clinics of patients receiving chemotherapy, captured chemotoxicities and respective severities. Patient telephone surveys assessed whether healthcare providers had addressed chemotoxicities to the patients’ satisfaction. RESULTS: Over a broad demographic of 497 patients receiving chemotherapy, 90% (95% CI 84–96%) with significant chemotoxicities (n = 107) reported that their providers had discussed toxicities with them; of these, 70% received a therapy management change, while among the rest, 17% desired a change in management. Of patients surveyed, 91% (95% CI 82–99%) were satisfied with their current chemotoxicity management. Clinician chart documentation varied greatly; descriptors rather than numerical grading scales were typically used. Although 93% of patients were willing to complete the PRO survey, only 50% thought that it would be acceptable to complete this survey at routine clinic visits. CONCLUSION: Use of PRO-CTCAE in routine clinical practice promotes systematic evaluation of symptomatic toxicities and improves the clarity, consistency, and efficiency of clinician documentation; however, methods to improve patient willingness to complete this tool routinely are needed.
format Online
Article
Text
id pubmed-7360011
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-73600112020-07-20 Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Wang, Tian Qi Samuel, Joseph N. Brown, M. Catherine Vennettilli, Ashlee Solomon, Hannah Eng, Lawson Liang, Mindy Gill, Gursharan Merali, Zahra Tian, Chenchen Cheng, Nicholas Y. H. Campbell, Matthew Patel, Devalben Liu, Ai Xin Liu, Geoffrey Howell, Doris Oncol Ther Original Research INTRODUCTION: Systematic documentation of chemotoxicities in outpatient clinics is challenging. Incorporating patient-reported outcome (PRO) measures in clinical workflows can be an efficient strategy to strengthen the assessment of symptomatic treatment toxicities in oncology clinical practice. We compared the adequateness, feasibility, and acceptability of toxicity documentation using systematic, prospective, application of the PRO Common Toxicity Criteria for Adverse Events (PRO-CTCAE) tool. METHODS: At a comprehensive cancer center, data abstraction of electronic health record reviews elucidated current methods and degree of chemotoxicity documentation. Web-based 32-item PRO-CTCAE questionnaires, administered in ambulatory clinics of patients receiving chemotherapy, captured chemotoxicities and respective severities. Patient telephone surveys assessed whether healthcare providers had addressed chemotoxicities to the patients’ satisfaction. RESULTS: Over a broad demographic of 497 patients receiving chemotherapy, 90% (95% CI 84–96%) with significant chemotoxicities (n = 107) reported that their providers had discussed toxicities with them; of these, 70% received a therapy management change, while among the rest, 17% desired a change in management. Of patients surveyed, 91% (95% CI 82–99%) were satisfied with their current chemotoxicity management. Clinician chart documentation varied greatly; descriptors rather than numerical grading scales were typically used. Although 93% of patients were willing to complete the PRO survey, only 50% thought that it would be acceptable to complete this survey at routine clinic visits. CONCLUSION: Use of PRO-CTCAE in routine clinical practice promotes systematic evaluation of symptomatic toxicities and improves the clarity, consistency, and efficiency of clinician documentation; however, methods to improve patient willingness to complete this tool routinely are needed. Springer Healthcare 2018-10-22 /pmc/articles/PMC7360011/ /pubmed/32700029 http://dx.doi.org/10.1007/s40487-018-0065-7 Text en © The Author(s) 2018 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research
Wang, Tian Qi
Samuel, Joseph N.
Brown, M. Catherine
Vennettilli, Ashlee
Solomon, Hannah
Eng, Lawson
Liang, Mindy
Gill, Gursharan
Merali, Zahra
Tian, Chenchen
Cheng, Nicholas Y. H.
Campbell, Matthew
Patel, Devalben
Liu, Ai Xin
Liu, Geoffrey
Howell, Doris
Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
title Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
title_full Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
title_fullStr Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
title_full_unstemmed Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
title_short Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
title_sort routine surveillance of chemotherapy toxicities in cancer patients using the patient-reported outcomes version of the common terminology criteria for adverse events (pro-ctcae)
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360011/
https://www.ncbi.nlm.nih.gov/pubmed/32700029
http://dx.doi.org/10.1007/s40487-018-0065-7
work_keys_str_mv AT wangtianqi routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae
AT samueljosephn routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae
AT brownmcatherine routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae
AT vennettilliashlee routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae
AT solomonhannah routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae
AT englawson routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae
AT liangmindy routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae
AT gillgursharan routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae
AT meralizahra routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae
AT tianchenchen routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae
AT chengnicholasyh routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae
AT campbellmatthew routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae
AT pateldevalben routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae
AT liuaixin routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae
AT liugeoffrey routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae
AT howelldoris routinesurveillanceofchemotherapytoxicitiesincancerpatientsusingthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcae